Findings

What do systematic reviews say?

216 questions · 218 findings · 21 reviews · Heart · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 30 · 13.8%GRADE not reported 1 · 0.5%Very low 49 · 22.5%Low 71 · 32.6%Moderate 48 · 22%High 19 · 8.7%

Closest answers

The findings closest to your search, judged one by one by TypeSafe's Jev model.

Direct match · question page
- High vs low blood pressure target · All‐cause mortality
  High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
  RR 1.33 [0.3, 5.9]
  3 studies · 737 participants
  Very low
Direct match · question page
- High vs low alpha‐linolenic acid omega‐3 fats · Cardiovascular events
  Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
  RR 0.95 [0.83, 1.07]
  5 studies · 19327 participants
  Low
Direct match · question page
- High vs low alpha‐linolenic acid omega‐3 fats · Coronary heart disease events
  Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
  RR 1 [0.82, 1.22]
  4 studies · 19061 participants
  Low
Direct match · question page
- High vs low alpha‐linolenic acid omega‐3 fats · Coronary heart disease mortality – CHD deaths
  Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
  RR 0.95 [0.72, 1.26]
  3 studies · 18353 participants
  Moderate
Direct match · question page
- High vs low blood pressure target · Cognitive deterioration
  High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
  RR 0.82 [0.45, 1.5]
  2 studies · 389 participants
  Low

High vs low omega‐3 fats

Serum high density lipoprotein – LCn3 – HDL, mmol/L · adults with or without existing CVD

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
no estimate extracted
30 studies · 46604 participants
High

High vs low omega‐3 fats

Serum high density lipoprotein – ALA – HDL, mmol/L · adults with or without existing CVD

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 1776 participants
Moderate

High vs low blood pressure target

Acute kidney injury · adults undergoing cardiac surgery with cardiopulmonary bypass

It is very uncertain whether high changes acute kidney injury compared with low blood pressure target (very low certainty).

1 finding from 1 review

High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
RR 1.3 [0.81, 2.08]
2 studies · 487 participants
Very low

High vs low blood pressure target

Cognitive deterioration · adults undergoing cardiac surgery with cardiopulmonary bypass

High showed no clear difference in cognitive deterioration compared with low blood pressure target (low certainty).

1 finding from 1 review

High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
RR 0.82 [0.45, 1.5]
2 studies · 389 participants
Low

High vs low blood pressure target

All‐cause mortality · adults undergoing cardiac surgery with cardiopulmonary bypass

It is very uncertain whether high changes all‐cause mortality compared with low blood pressure target (very low certainty).

1 finding from 1 review

High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
RR 1.33 [0.3, 5.9]
3 studies · 737 participants
Very low

High vs low blood pressure target

Quality of life · adults undergoing cardiac surgery with cardiopulmonary bypass

It is very uncertain whether high changes quality of life compared with low blood pressure target (very low certainty).

1 finding from 1 review

High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
RR 0.78 [0.3, 2.01]
1 study · 218 participants
Very low

High vs low blood pressure target

Acute ischaemic stroke · adults undergoing cardiac surgery with cardiopulmonary bypass

It is very uncertain whether high changes acute ischaemic stroke compared with low blood pressure target (very low certainty).

1 finding from 1 review

High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
RR 1.29 [0.07, 23.63]
2 studies · 426 participants
Very low

High vs low blood pressure target

Length of hospital stay · adults undergoing cardiac surgery with cardiopulmonary bypass

1 finding from 1 review

High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 540 participants
Very low

High vs low blood pressure target

Perioperative transfusion of blood products · adults undergoing cardiac surgery with cardiopulmonary bypass

1 finding from 1 review

High versus low blood pressure targets for cardiac surgery while on cardiopulmonary bypass 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 540 participants
Very low

High vs low long‐chain omega‐3 fats

All‐cause mortality – deaths · adults with or without existing CVD

High showed no clear difference in all‐cause mortality – deaths compared with low long‐chain omega‐3 fats (high certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 0.97 [0.93, 1.01]
45 studies · 143693 participants
High

High vs low ALA omega‐3 fats

All‐cause mortality – deaths · adults with or without existing CVD

High showed no clear difference in all‐cause mortality – deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 1.01 [0.84, 1.2]
5 studies · 19327 participants
Moderate

High vs low ALA omega‐3 fats

Cardiovascular mortality · adults with or without existing CVD

High showed no clear difference in cardiovascular mortality – cardiovascular deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 0.96 [0.74, 1.25]
4 studies · 18619 participants
Moderate

High vs low ALA omega‐3 fats

Cardiovascular events · adults with or without existing CVD

High showed no clear difference in cardiovascular events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 0.95 [0.83, 1.07]
5 studies · 19327 participants
Low

High vs low ALA omega‐3 fats

Coronary heart disease mortality – CHD deaths · adults with or without existing CVD

High showed no clear difference in coronary heart disease mortality – CHD deaths compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 0.95 [0.72, 1.26]
3 studies · 18353 participants
Moderate

High vs low ALA omega‐3 fats

CHD events · adults with or without existing CVD

High showed no clear difference in coronary heart disease events compared with low alpha‐linolenic acid omega‐3 fats (low certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 1 [0.82, 1.22]
4 studies · 19061 participants
Low

High vs low ALA omega‐3 fats

Stroke · adults with or without existing CVD

It is very uncertain whether high changes stroke compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 1.15 [0.66, 2.01]
5 studies · 19327 participants
Very low

High vs low ALA omega‐3 fats

Arrhythmias · adults with or without existing CVD

High probably leads to lower arrhythmias compared with low alpha‐linolenic acid omega‐3 fats (moderate certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 0.73 [0.55, 0.97]
2 studies · 4912 participants
Moderate

High vs low ALA omega‐3 fats

Harms: bleeding · adults with or without existing CVD

The review found no eligible studies for this question.

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

High vs low ALA omega‐3 fats

Harms: pulmonary embolus or DVT · adults with or without existing CVD

It is very uncertain whether high changes harms: pulmonary embolus or DVT compared with low alpha‐linolenic acid omega‐3 fats (very low certainty).

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
RR 0.32 [0.01, 7.8]
1 study · 708 participants
Very low

High vs low omega‐3 fats

Outcomes All in trials of 12 to 72 months' duration · adults with or without existing CVD

The review found no eligible studies for this question.

1 finding from 1 review

Omega‐3 fatty acids for the primary and secondary prevention of cardiovascular disease 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found